Citigroup Inc. raised its stake in Schrodinger, Inc. (NASDAQ:SDGR – Free Report) by 122.5% during the 3rd quarter, HoldingsChannel reports. The firm owned 155,209 shares of the company’s stock after acquiring an additional 85,448 shares during the quarter. Citigroup Inc.’s holdings in Schrodinger were worth $3,113,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently modified their holdings of the stock. State of Wyoming acquired a new stake in shares of Schrodinger in the second quarter valued at about $39,000. SBI Securities Co. Ltd. boosted its holdings in Schrodinger by 110.4% in the 3rd quarter. SBI Securities Co. Ltd. now owns 2,127 shares of the company’s stock worth $43,000 after acquiring an additional 1,116 shares during the period. ANTIPODES PARTNERS Ltd grew its position in Schrodinger by 292.3% in the third quarter. ANTIPODES PARTNERS Ltd now owns 4,912 shares of the company’s stock valued at $99,000 after acquiring an additional 3,660 shares in the last quarter. Canada Pension Plan Investment Board purchased a new stake in shares of Schrodinger during the second quarter valued at approximately $143,000. Finally, Portland Investment Counsel Inc. purchased a new stake in shares of Schrodinger during the second quarter valued at approximately $206,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Schrodinger Stock Performance
Shares of SDGR stock opened at $13.03 on Friday. The stock has a market capitalization of $959.92 million, a price-to-earnings ratio of -9.18 and a beta of 1.57. Schrodinger, Inc. has a one year low of $11.11 and a one year high of $27.63. The company’s 50-day simple moving average is $14.88 and its 200-day simple moving average is $17.65.
Wall Street Analyst Weigh In
SDGR has been the subject of several analyst reports. Bank of America upgraded shares of Schrodinger from a “neutral” rating to a “buy” rating and set a $24.00 target price for the company in a research note on Monday, December 15th. UBS Group started coverage on Schrodinger in a research note on Wednesday, January 7th. They set a “neutral” rating and a $18.00 target price for the company. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Schrodinger in a research report on Friday, January 9th. TD Cowen reissued a “buy” rating on shares of Schrodinger in a report on Thursday, January 8th. Finally, Wall Street Zen upgraded Schrodinger from a “sell” rating to a “hold” rating in a research note on Saturday, January 31st. Four analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $21.75.
Check Out Our Latest Analysis on SDGR
Schrodinger Company Profile
Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.
Recommended Stories
- Five stocks we like better than Schrodinger
- Silver Is the New Oil—And the World’s Running Dry
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- What happened in Cyprus could be coming here
- Elon Musk’s $1 Quadrillion AI IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Want to see what other hedge funds are holding SDGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Schrodinger, Inc. (NASDAQ:SDGR – Free Report).
Receive News & Ratings for Schrodinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrodinger and related companies with MarketBeat.com's FREE daily email newsletter.
